Andes

Andes, a biotechnology company established in 2018, is focused on developing microbial technology to address climate change through agricultural applications. Founded by CEO Gonzalo Fuenzalida and CTO Tania Timmermann, the company originated from Fuenzalida's background in investment banking and passion for nature, combined with insights from renowned scientists. Based in Alameda, California, Andes operates at the intersection of biology and climate tech.

The company's business model centers on two primary technological platforms: nitrogen fixation and carbon dioxide removal. The first, a product called Microprime, involves treating seeds with beneficial microbes that colonize the plant's roots. This process enables crops, such as corn, to fix nitrogen from the atmosphere, thereby reducing the dependency on synthetic nitrogen fertilizers, which are a significant source of greenhouse gas emissions. The first generation of these treated seeds aims to provide the equivalent of 30 to 50 lbs/acre of nitrogen. This technology is designed for seamless integration into existing farming practices, allowing the specialized seeds to be stored and handled like conventional ones.

The second core area of business is a nature-based carbon capture solution. Andes has developed proprietary microorganisms that are added to the soil along with seeds for crops like corn, soybean, and wheat. These microbes grow with the plant roots and accelerate the conversion of atmospheric CO2 into stable minerals within the soil, a process called microbial carbon mineralization. This method provides a form of permanent carbon storage, sequestering CO2 for thousands of years. The company generates revenue by creating and selling validated carbon removal credits to organizations aiming to meet sustainability goals. For farmers, enrolling in the Andes Carbon Removal Program offers a new revenue stream, potentially increasing their net income by up to 25-30%, without requiring upfront investment.

Andes has successfully raised a total of $38 million in funding through multiple Series A rounds, with the latest in March 2023. Key investors include Leaps by Bayer, Cavallo Ventures, Voyager VC, and Yamaha Motor Ventures. The capital is being used to expand the commercialization of its technologies, increase partnerships with farmers across the U.S. Midwest, and further research and development. The technology has already been deployed across tens of thousands of acres, removing a reported 50,000 tonnes of CO2.

Keywords: microbial seed treatment, nitrogen fixation, carbon dioxide removal, agricultural biotechnology, soil carbon sequestration, Microprime, microbial carbon mineralization, agtech, climate tech, carbon credits, sustainable agriculture, biological fertilizers, soil health, carbon capture, farm income, Gonzalo Fuenzalida, Tania Timmermann, Leaps by Bayer, Voyager VC, soil inorganic carbon